These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Biotech firm Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down manufacturing amid weakening demand for its COVID-19 vaccine. The ...

Of the 11 new unicorns in January, five came from healthcare, including companies working on genetic research, drug ...

Darwin's theory of natural selection provides an explanation for why organisms develop traits that help them survive and reproduce.

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

Holmes was first seen with Evans at Burning Man festival in 2018, per the New York Times. Evans is graduate of the Massachusetts Institute of Technology. His father, Bill Evans, owns and operates ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

Global net sales of EPKINLY/TEPKINLY were USD 281 million in 2024. Net product sales in the U.S. and Japan by Genmab were DKK 1,743 million in 2024 compared to DKK 421 million in 2023. EPKINLY was ...

AB (market cap: $16.28M), a company in the development stage, provided insights into its Q4 2024 performance and future plans during its recent earnings call. The company is advancing its Neola ...

Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...